메뉴 바로가기 본문 바로가기
Products01 AlphaLiquid®01

colorectal cancer mutations

The AlphaLiquid® Series
AlphaLiquid®
10
AlphaLiquid®
100
AlphaLiquid®
1000
AlphaLiquid®
Screening
AlphaLiquid®
MRD
Companion diagnostics
Recurrence & metastasis
monitoring
Biomarker discovery
Early diagnosis
Personalized residual
disease monitoring
  • AlphaLiquid®
    10
  • AlphaLiquid®
    100
  • AlphaLiquid®
    1000

Treatment selection

Recurrence monitoring

colorectal cancer mutations, AlphaLiquid, pan-cancer assay, minimal residual disease monitoring, detect cancer early | IMBdx AlphaLiquid®
Screening

Early detection

colorectal cancer mutations, AlphaLiquid, pan-cancer assay, minimal residual disease monitoring, detect cancer early | IMBdx AlphaLiquid®
MRD

Personalized residual
disease monitoring

AlphaLiquid®10(Colon)
  • AlphaLiquid®10 is designed to detect mutations in 10 colorectal cancer-related genes.
  • It can be used in companion diagnostics to provide information on whether recurrence or metastasis might be occurring after treatment.
  • Target cancer

    Colorectal cancer

  • Detectable mutations

    SNV, Indel